Renin--angiotensin antagonists and the regulation of blood pressure
- PMID: 185095
Renin--angiotensin antagonists and the regulation of blood pressure
Abstract
The role of the renin--angiotensin system in the regulation of blood pressure in dogs and in human subjects was assessed by the use of the nonapeptide converting enzyme inhibitor (CEI), permitting the following conclusions: 1) In the normal, sodium replete dog, the renin--angiotensin system plays little role in the regulation of blood pressure. 2) As sodium depletion progresses, the renin--angiotensin system becomes increasingly important in the maintenance of blood pressure. In the markedly hypovolemic animal, blocking the conversion of angiotensin I to angiotensin II leads to prolonged hypotension of shock-like levels. 3) The renin--angiotensin system is responsible for the initiation of renovascular hypertension. Blood pressure does not rise during chronic renal artery constriction when the generation of angiotensin II is prevented by the CEI. Although angiotensin II is essential for the initiation of the elevated blood pressure, the renin--angiotensin system plays a decreasing role in the maintenance of the chronic hypertension as sodium and water are retained, and plasma volume increases. 4) In congestive failure induced in the conscious dog by circulatory impairment, the renin--angiotensin--aldosterone system plays an essential role in the compensatory response. During chronic administration of the CEI, the animal cannot compensate even for a relatively mild degree of constriction, and remains hypotensive. In the dog with congestive failure, as in the dog with renovascular hypertension, plasma renin activity (PRA) and plasma aldosterone are elevated early in the syndrome; during this phase, injection of the nonapeptide produces a marked drop in blood pressure. With the retention of sodium and water, and expansion of plasma and extravascular fluid volumes, PRA and plasma aldosterone return to control levels in the new steady state. The inhibitor no longer produces a drop in blood pressure. Thus, the sequential changes in the renin--angiotensin--aldosterone system are remarkably similar in renovascular hypertension and congestive failure. 5) In the normal, salt replete human subject the renin--angiotensin system plays little role in the regulation of blood pressure either in the recumbent or upright posture. However, with relatively mild sodium depletion, the CEI transiently lowers blood pressure even in the recumbent subject. In the absence of angiotensin II such sodium-depleted subjects are unable to compensate when tilted upright, and faint within minutes.
Similar articles
-
The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.J Clin Invest. 1976 Jun;57(6):1606-17. doi: 10.1172/JCI108431. J Clin Invest. 1976. PMID: 180056 Free PMC article.
-
The role of the renin--angiotensin--aldosterone system in cardiovascular homeostasis in normal man.Clin Sci Mol Med Suppl. 1975 Jun;2:49s-52s. Clin Sci Mol Med Suppl. 1975. PMID: 1077790
-
Angiotensin II blockade and the functions of the renin-angiotensin system.Prog Biochem Pharmacol. 1976;12:1-15. Prog Biochem Pharmacol. 1976. PMID: 798202 Review.
-
Mechanisms involved in two-kidney renal hypertension induced by constriction of one renal artery.Circ Res. 1977 May;40(5 Suppl 1):I29-35. Circ Res. 1977. PMID: 870229
-
The pathophysiology of renovascular hypertension.J Hypertens Suppl. 1986 Oct;4(4):S95-103. J Hypertens Suppl. 1986. PMID: 3534187 Review.
Cited by
-
Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.Proc Natl Acad Sci U S A. 1980 Sep;77(9):5476-9. doi: 10.1073/pnas.77.9.5476. Proc Natl Acad Sci U S A. 1980. PMID: 6159648 Free PMC article.
-
Location on chromosome 1 of Rnr, a gene that regulates renin in the submaxillary gland of the mouse.Proc Natl Acad Sci U S A. 1978 Nov;75(11):5623-6. doi: 10.1073/pnas.75.11.5623. Proc Natl Acad Sci U S A. 1978. PMID: 281712 Free PMC article.
-
The renin/angiotensin system.Br J Clin Pharmacol. 1981 Nov;12(5):605-12. doi: 10.1111/j.1365-2125.1981.tb01278.x. Br J Clin Pharmacol. 1981. PMID: 6174135 Free PMC article. No abstract available.
-
Converting enzyme inhibition and blood pressure regulation.Agents Actions. 1976 Jul;6(4):538-42. doi: 10.1007/BF01973276. Agents Actions. 1976. PMID: 183489 Review. No abstract available.
-
Effects of SQ 14.225, an orally active inhibitor of angiotensin-converting enzyme, on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.Basic Res Cardiol. 1981 May-Jun;76(3):344-51. doi: 10.1007/BF01907777. Basic Res Cardiol. 1981. PMID: 6455994
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials